Mad Money's Cramer takes a look at speculative stock, Solazyme, but cautions investors to follow the six steps to analyze the stock first, and then if you can stomach the risk, use only limit orders to buy.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT